{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:22:07Z","timestamp":1761016927084},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T00:00:00Z","timestamp":1312761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10565-011-9197-3","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T02:32:26Z","timestamp":1312684346000},"page":"425-438","source":"Crossref","is-referenced-by-count":8,"title":["NT-proBNP as a biomarker for the assessment of a potential cardiovascular drug-induced liability in beagle dogs"],"prefix":"10.1007","volume":"27","author":[{"given":"Federica","family":"Crivellente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Tontodonati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Fasdelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Casartelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Dorigatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Faustinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Cristofori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,8]]},"reference":[{"key":"9197_CR1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1292\/jvms.61.523","volume":"61","author":"K Asano","year":"1974","unstructured":"Asano K, Masuda K, Okumura M, Kadosawa T, Fujinaga T. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure. J Vet Med Sci. 1974;61:523\u20139.","journal-title":"J Vet Med Sci"},{"key":"9197_CR2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.amjcard.2004.10.031","volume":"95","author":"WM Book","year":"2005","unstructured":"Book WM, Hott BJ, McConnell M. B-type natriuretic peptide levels in adults with congenital heart disease and right ventricular failure. Am J Cardiol. 2005;95:545\u20136.","journal-title":"Am J Cardiol"},{"issue":"3","key":"9197_CR3","first-page":"552","volume":"130","author":"M Cantin","year":"1988","unstructured":"Cantin M, Thibault G, Ding J, Gutkowska J, Garcia R, Jasmin G, et al. ANF in experimental congestive heart failure. Am J Pathol. 1988;130(3):552\u201368.","journal-title":"Am J Pathol"},{"key":"9197_CR4","doi-asserted-by":"crossref","unstructured":"Casartelli A, Lanzoni A, Comelli R, Crivellente F, Defazio R, Dorigatti R, et al. A novel and integrated approach for the identification and characterization of drug induced cardiac toxicity in the dog. Tox Path. 2011. doi: 10.1177\/0192623310390704 . in press.","DOI":"10.1177\/0192623310390704"},{"key":"9197_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jvc.2010.01.001","volume":"12","author":"SA Collins","year":"2010","unstructured":"Collins SA, Patteson MW, Connolly DJ, Brodbelt DC, Torrance AG, Harris JD. Effect of sample handling on serum N-terminal proB-type natriuretic peptide concentration in normal dogs and dogs with heart disease. J Vet Cardiol. 2010;12:41\u20138.","journal-title":"J Vet Cardiol"},{"issue":"5","key":"9197_CR6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1359-6349(07)70034-4","volume":"5","author":"PA Duffy","year":"2007","unstructured":"Duffy PA, Betton G, Horner S, Horner J, Cotton P, McMahon N, et al. Biomarkers for safety and toxicology: drug induced cardiac injury and dysfunction. Eur J Cancer Suppl. 2007;5(5):143\u201351.","journal-title":"Eur J Cancer Suppl"},{"key":"9197_CR7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1939-1676.2008.0161.x","volume":"22","author":"Y Hori","year":"2008","unstructured":"Hori Y, Tsubaki M, Katou A, Ono Y, Yonezawa T, Li X, et al. Evaluation of NT-proBNP and CT-ANP as markers of concentric hyperthrophy in dogs with a model of compensated aortic stenosis. J Vet Intern Med. 2008;22:1118\u201323.","journal-title":"J Vet Intern Med"},{"key":"9197_CR8","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1373\/clinchem.2003.021311","volume":"49","author":"J Ishii","year":"2003","unstructured":"Ishii J, Cui W, Kitagawa F, Kuno T, Nakamura Y, Naruse H, et al. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem. 2003;49:2020\u20136.","journal-title":"Clin Chem"},{"key":"9197_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-5273(99)00141-2","volume":"71","author":"JE Kal","year":"1999","unstructured":"Kal JE, Van Wezel HB, Vergroesen I. A critical appraisal of the rate pressure product as index of myocardial oxygen consumption for the study of metabolic coronary flow regulation. Int J Cardiol. 1999;71:141\u20138.","journal-title":"Int J Cardiol"},{"key":"9197_CR10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.amjcard.2004.10.014","volume":"95","author":"YM Law","year":"2005","unstructured":"Law YM, Keller BB, Feingold BM, Boyle GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol. 2005;95:474\u20138.","journal-title":"Am J Cardiol"},{"key":"9197_CR11","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/01.CIR.91.10.2642","volume":"91","author":"S Litwin","year":"1995","unstructured":"Litwin S, Katz S, Weinberg E, Lorell B, Aurigemma G, Douglas P. Serial echocardiographic\u2013Doppler assessment of left ventricular geomeometry and function in rats with pressure-overload hypertrophy: chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation. 1995;91:2642\u201354.","journal-title":"Circulation"},{"key":"9197_CR12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-1119(02)00676-5","volume":"292","author":"Z Liu","year":"2002","unstructured":"Liu Z, Wiedmeyer CE, Sisson DD, Solter PF. Cloning and characterization of feline brain natriuretic peptide. Gene. 2002;292:183\u201390.","journal-title":"Gene"},{"key":"9197_CR13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1748-5827.2009.00889.x","volume":"51","author":"W Moonarmart","year":"2010","unstructured":"Moonarmart W, Boswood A, Luis Fuentes V, Brodbelt D, Souttar K, Elliott J. N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease. J Small Anim Pract. 2010;51:84\u201396.","journal-title":"J Small Anim Pract"},{"key":"9197_CR14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/14737159.6.5.649","volume":"6","author":"AM Morello","year":"2006","unstructured":"Morello AM, Januzzi JL. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure. Expert Rev Mol Diagn. 2006;6:649\u201362.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"9197_CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","volume":"32","author":"H Olson","year":"2000","unstructured":"Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Rugul Toxicol Pharmacol. 2000;32(1):56\u201367.","journal-title":"Rugul Toxicol Pharmacol"},{"key":"9197_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2460\/ajvr.68.1.42","volume":"68","author":"MA Oyama","year":"2007","unstructured":"Oyama MA, Sisson DD, Solter PF. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am J Vet Res. 2007;68:42\u20137.","journal-title":"Am J Vet Res"},{"issue":"10","key":"9197_CR17","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2460\/javma.232.10.1496","volume":"232","author":"MA Oyama","year":"2008","unstructured":"Oyama MA, Fox PR, Rush JE, Rozanski EA, Lesser M. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc. 2008;232(10):1496\u2013503.","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"9197_CR18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jash.2008.02.001","volume":"2","author":"KN Pandey","year":"2008","unstructured":"Pandey KN. Emerging roles of natriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular regulation. J Am Soc Hypertens. 2008;2(4):210\u201326.","journal-title":"J Am Soc Hypertens"},{"issue":"6","key":"9197_CR19","first-page":"344","volume":"47","author":"FK Panou","year":"2006","unstructured":"Panou FK, Kotseroglou VK, Lakoumentas JA, Chrysanthopoulou SA, Armeniakos JA, Stratigou T, et al. Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. Hellenic J Cardiol. 2006;47(6):344\u201351.","journal-title":"Hellenic J Cardiol"},{"issue":"1","key":"9197_CR20","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1007\/s11259-009-9282-8","volume":"33","author":"D Piantedosi","year":"2009","unstructured":"Piantedosi D, Cortese L, Di Loria A, Brignola G, Prisco M, Persechino A, et al. Plasma atrial natriuretic peptide (proANP 31\u201367), B-type natriuretic peptide (Nt-proBNP) and endothelin-1 (ET-1) concentrations in dogs with chronic degenerative valvular disease (CDVD). Vet Res Commun. 2009;33(1):S197\u2013200.","journal-title":"Vet Res Commun"},{"key":"9197_CR21","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1939-1676.2009.0373.x","volume":"23","author":"E Raffan","year":"2009","unstructured":"Raffan E, Loureiro J, Dukes-McEwan J, Fonfara S, James R, Swift S, et al. The cardiac biomarker NT-proBNP is increased in dogs with azotemia. J Vet Intern Med. 2009;23:1184\u20139.","journal-title":"J Vet Intern Med"},{"key":"9197_CR22","doi-asserted-by":"crossref","unstructured":"Roche BM, Kijtawornrat AK, Lolly JL, Schmidt JJ, Nishijima Y, Hamlin RL. The effects of 12-weeks of ventricular pacing on cardiac performance and BNP levels in dogs. Poster presented at the 6th Annual Meeting of Safety Pharmacology Society 2007.","DOI":"10.1016\/j.vascn.2007.02.024"},{"issue":"5","key":"9197_CR23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80013-6","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimension echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358\u201367.","journal-title":"J Am Soc Echocardiogr"},{"key":"9197_CR24","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.jvc.2009.02.001","volume":"11","author":"MK Schmidt","year":"2009","unstructured":"Schmidt MK, Reynolds CA, Estrada AH, Prosek R, Maisenbacher HW, Sleeper MM, et al. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study. J Vet Cardiol. 2009;11:S81\u20136.","journal-title":"J Vet Cardiol"},{"key":"9197_CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jvc.2009.07.001","volume":"11","author":"F Serres","year":"2009","unstructured":"Serres F, Pouchelon JL, Poujol L, Lefebvre HP, Trumel C, Daste T, et al. Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission. J Vet Cardiol. 2009;11:103\u201321.","journal-title":"J Vet Cardiol"},{"key":"9197_CR26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.cvsm.2004.05.005","volume":"34","author":"DD Sisson","year":"2004","unstructured":"Sisson DD. Neuroendocrine evaluation of cardiac disease. Vet Clin North Am Small Anim Pract. 2004;34:1105\u201326.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"1","key":"9197_CR27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1939-165X.2008.00002.x","volume":"37","author":"PF Solter","year":"2008","unstructured":"Solter PF, Oyama MA, Sisson DD. Canine heterophilic antibodies as a source of false-positive B-type natriuretic peptide sandwich ELISA results. Vet Clin Pathol. 2008;37(1):86\u201395.","journal-title":"Vet Clin Pathol"},{"key":"9197_CR28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/332078a0","volume":"332","author":"T Sudoh","year":"1988","unstructured":"Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988;332:78\u201381.","journal-title":"Nature"},{"issue":"7","key":"9197_CR29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1292\/jvms.71.925","volume":"71","author":"N Takemura","year":"2009","unstructured":"Takemura N, Toda N, Miyagawa Y, Asano K, Tejima K, Kanno N, et al. Evaluation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency. J Vet Med Sci. 2009;71(7):925\u20139.","journal-title":"J Vet Med Sci"},{"key":"9197_CR30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1440-1681.2003.03841.x","volume":"30","author":"CJ Thomas","year":"2003","unstructured":"Thomas CJ, Woods RL. Haemodynamic action of B-type natriuretic peptide substantially outlasts its plasma half-life in conscious dogs. Clin Exp Pharmacol Physiol. 2003;30:369\u201375.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"9197_CR31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2217\/bmm.10.5","volume":"4","author":"M Vanderheyden","year":"2010","unstructured":"Vanderheyden M, Vrints C, Verstreken S, Bartunek J, Beunk J, Goethals M. B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications. Biomark Med. 2010;4(2):315\u201320.","journal-title":"Biomark Med"},{"key":"9197_CR32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","volume":"90","author":"H Yasue","year":"1994","unstructured":"Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195\u2013203.","journal-title":"Circulation"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-011-9197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10565-011-9197-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-011-9197-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T21:19:07Z","timestamp":1560460747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10565-011-9197-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,8]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9197"],"URL":"https:\/\/doi.org\/10.1007\/s10565-011-9197-3","relation":{},"ISSN":["0742-2091","1573-6822"],"issn-type":[{"value":"0742-2091","type":"print"},{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,8]]}}}